AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Teva Pharmaceutical Industries Ltd.

Major Shareholding Notification Mar 1, 2024

7082_rns_2024-03-01_26128db4-4ff0-44a6-ade3-8bb9a0826d75.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response ... 0.5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

(Print or Type Responses)

1. Name and Address of Reporting Person
Drapé Eric
2. Issuer Name and Ticker or Trading Symbol
Teva Pharmaceutical Industries Limited TEVA
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director
10% Owner
(Last)
(First)
(Middle)
C/O Teva Pharmaceutical Industries Ltd.
124 Dvora HaNevi'a St.,
3. Date of Earliest Transaction (Month/Day/Year)
02/28/2024
Officer (give title below)
Other (specify below)
Executive VP Global Operations
(Street)
Tel Aviv, L3 6944020
(City)
(State)
(Zip)
4. If Amendment, Date Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security 2. Transaction 2A. Deemed 3. Transaction 4. Securities Acquired 5. Amount of Securities Beneficially 7. Nature
(Instr. 3) Date Execution Date, if Code (A) or Disposed of (D) Owned Following Reported Ownership of Indirect
(Month/Day/Year) any (Instr. 8) (Instr. 3, 4 and 5) Transaction(s) Form: Beneficial
(Month/Day/Year) (Instr. 3 and 4) Direct (D) Ownership
(A) or Indirect (Instr. 4)
Or
Code Amount (D) Price (Instr. 4)
'Ordinary Shares (1) 02/28/2024 M 19,515 A (2) 19,516 D
Ordinary Shares (1)
02/28/2024
1 9.701
----------------------------------- -- --- ------- --





















!
"

#
\$
%
"
&
'
(
)
"

*
+
,
:

;
<
=
1
2
,
)
-
1

+
!



?

@
A

B
C





?



E
@

B


N



O







D

@
H
B

D


B



@
I
J
E
F
@

B




@



C
?



E
@

B

B
E
F


@

B


I
J
E

L
B

@




M





H
B

G

@





K


E

B
C
L
B

@




M


G

@





N



D

@
N
E
F


@

&
'
-
1



P
C


E
E
R




G


















)
"
-

+
/
,
'
&
"
0
1

%
'
-
2
3
"
0

4
1
&
5
"
6
9
&
6
)
-
1

3
2
)
'
6
-
1

+
3
6
(
"
&
)
'
!
"

-
+
,
F
O
Q





@
I
J

E


Q
A


D

@




I
J
S



@
B




@
F


@
L
B

@




M


F




B

S
B


C
@











@
I
J
S



@
B

?
I
J

E


Q
A


@








4
'
+
!
7

8
9
6
"
0
&
'
)
"
-
>


?

@
A




N
O
B
F

@



K


E

B
B
C

T



A



U



D

@
E
F


@
E
F


@

G

@









G

@





N
O
B
F

@
B


@
A
P
F
O
Q

B
C


C



P
F
O
Q


B
C






D

@

W



S
E
F


@
X
B

O

C
V

C

E

A




D

@

W


E
F


@

Z


E
@



G




E
@






P

@
F

B
C

G




E
@
V

C

E

A

W



S
G

@




Y
@


E

\
]
2
!
6
)
'
3

4
^
"
-
2
3
6
"
_
H
B

[









L


T


@

N














X
B
A
W


U

Y
S
B

@

B


?



E
@

B


G

G

@





G

@














`
a
?












O


Q

S

@


Q

N
O


E




S
B

@









b
a
I

E


@

E





F


@

S

@


E
B

@

U
@



U
@

B

E

D



@
A
O
B
C











E
B
C
W

E

F


@
A



S

@

B


@


B










B


@
B
S
@











C
@
c
F
O



Y
B
F
E




H
B
O
S


@

B


H
O
O

@


E

D
A
F

  • baIE - @E -F@-S @EB@U@-U @B-ED@ AO@B - -B@ BS@C@ cFOY BF-E HBOS @BHOO@ E DAF BC - - da? @- E@B-SB@@ XB-OW CE@SF- @BYFAQe@-USABS@Q@ -SB@US- BPDOQ-faYS- @ FOQ-BC -RF@BQ BAQ@ -SB@US- B@ED-@JW@ BAUBQAU@B EB@BW@ D @UBC@ - @E -F@ A@?QAGga? S-ESB@HBAFO WU @D-US-E? -W- BAOFA@S@- E@B @S-E -UC-BO@BEAF D? -SB@US- BF-@h @BS-DFSB-RF @Q IH @C@ F-B EF-@ BA-BC@ F-CFACB-O@B-UU@ FOQ-BC -BA@E S-@S-E*'j6),&"-
    -
  • iaY @-E -F@ W-U@BXQ-FW@ D @BE BCXQ-FXQ-FXQ-FD @BXQ-F

    - BDV-UWh @BeCE@B-IES

k U@F-BCYSB-@UK- B@ Reminder: Report on a separate line for each class of securities beneficially owned directly.

  • * If the form is filed by more than one reporting person, see Instruction 4(b)(v).
  • ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 18f(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of in this form are not required to respond unless the form displays a currently valid OMB Number.

Talk to a Data Expert

Have a question? We'll get back to you promptly.